Drug
Oseltamivir clinical trials
Also written Tamiflu.
- studies test it
- 89
- open now
- 4
- in phase 3
- 15
- first study started
- 2001
Keep track of what changes. Save the Oseltamivir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
- Tamiflu
- 37
Studies by the year they started
89 studies that test it; most in 2009 (14)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 14 |
| 2010 | 11 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 8 |
| 2021 | 4 |
| 2023 | 4 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 31
- Phase 2
- 17
- Phase 3
- 15
- Phase 4
- 25
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 38 · Other 51
Hoffmann-La Roche (16) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · University of Oxford (5) · Capital Medical University (4) · Tongji Hospital (4) · Chinese University of Hong Kong (3) · GlaxoSmithKline (3) · MedImmune LLC (2)
Often tested with
Tested in the same studies.
Zanamivir (6) · Pimodivir (3) · Peramivir (3) · Amantadine (3) · Baloxavir (3) · Hydroxychloroquine (2) · Azithromycin (2) · MEDI8852 (2)
Studies
Open first, then newest update. How each study uses Oseltamivir is read from its arms, and is right about nine times in ten.
Testing it · 89
- Randomised Evaluation of COVID-19 TherapyRecruitingPhase 3University of OxfordNCT04381936Written as Oseltamivir
- A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingPhase 2University of OxfordNCT05648448Written as Oseltamivir
- Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based SettingRecruitingPhase 3Capital Medical UniversityNCT07236814Written as Oseltamivir
- Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based SettingNot yet recruitingNot applicableCapital Medical UniversityNCT06762587Written as Oseltamivir
- Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of InfluenzaActive, not recruitingPhase 3Chinese University of Hong KongNCT03901001Written as sirolimus and oseltamivir
- Post-exposure Influenza Prophylaxis in a Hospital SettingActive, not recruitingPhase 3University Medical Centre LjubljanaNCT07496736Written as Oseltamivir
- Study of Acute Uncomplicated Seasonal Influenza A in Adult SubjectsCompletedPhase 2Janssen Research & Development, LLCNCT02342249Written as Oseltamivir 75 mg
- A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872CompletedPhase 1Alios Biopharma Inc.NCT02888327Written as Oseltamivir
- A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult SubjectsCompletedPhase 1Nanjing Zenshine PharmaceuticalsNCT06057103Written as Oseltamivir
- A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy VolunteersCompletedPhase 1Jiangxi Qingfeng Pharmaceutical Co. Ltd.NCT05789342Written as Oseltamivir
- Rapid Empiric Treatment With Oseltamivir Study (RETOS)CompletedPhase 4University of LouisvilleNCT01248715Written as oseltamivir
- Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult SubjectsCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT04982913Written as HEC116094
- Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy VolunteersCompletedPhase 4Austarpharma, LLCNCT04536415Written as Oseltamivir Phosphate 75 mg capsules
- Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza ACompletedPhase 2Visterra, Inc.NCT03040141Written as Low dose of VIS410
- Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral SuspensionCompletedPhase 1The Affiliated Hospital of Qingdao UniversityNCT05297968Written as Oseltamivir Phosphate For Oral Suspension/Tamiflu
- Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCTCompletedPhase 3Shehnoor AzharNCT04338698Written as Oseltamivir
- Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and OseltamivirCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05108051Written as Oseltamivir
- Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference ProductCompletedPhase 1Laboratorios Andromaco S.A.NCT05083325Written as Oseltamivir 75mg Test Drug capsules
- The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart FailureStatus unknownNot applicableTongji HospitalNCT05008679Written as Oseltamivir
- Open-label Study of Neuraminidase Inhibitor Treatment in STEMI PatientsStatus unknownPhase 4Tongji HospitalNCT04684498Written as Oseltamivir phosphate capsules
See all 89 studies that test Oseltamivir →
Given in every arm · 14 — Oseltamivir is usual care beside what is tested
- Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsRecruitingPhase 2M.D. Anderson Cancer CenterNCT04712539Written as Oseltamivir
- Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With InfluenzaTerminatedPhase 2/3Weill Medical College of Cornell UniversityNCT05170009Written as Oseltamivir
- IMU-838 and Oseltamivir in the Treatment of COVID-19CompletedPhase 2University Hospitals Coventry and Warwickshire NHS TrustNCT04516915Written as Oseltamivir
- Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.TerminatedPhase 2University Hospital, LilleNCT03212716Written as Oseltamivir
- Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With InfluenzaTerminatedPhase 2GlaxoSmithKlineNCT02927431Written as Oseltamivir 75 mg
- Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 PatientsStatus unknownPhase 1Indonesia UniversityNCT04457609Written as Oseltamivir
- Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019Status unknownEarly Phase 1Fuzhou General HospitalNCT04371601Written as Oseltamivir
- A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A InfectionCompletedPhase 2Janssen Research & Development, LLCNCT02532283Written as Oseltamivir
- Treatment of Severe Influenza A InfectionCompletedPhase 3The University of Hong KongNCT02108366Written as Oseltamivir
- A Pharmacokinetics Study of Favipiravir in Patients With Severe InfluenzaCompletedPhase 2Capital Medical UniversityNCT03394209Written as Oseltamivir 75Mg Capsule
- Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.WithdrawnPhase 2MedImmune LLCNCT03028909Written as Oseltamivir
- A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A InfectionCompletedPhase 2Genentech, Inc.NCT02293863Written as Oseltamivir
- Influenza Management With Polyherbal FormulationStatus unknownNot applicableComposite Interceptive Med ScienceNCT03365336Written as Oseltamivir 75mg
- Interferon Alpha Lozenges Plus Oseltamivir for Influenza TreatmentCompletedPhase 2Ainos, Inc. (f/k/a Amarillo Biosciences Inc.NCT01146535Written as Oseltamivir
As the comparator · 23 — what is tested is compared with Oseltamivir
- Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With InfluenzaRecruitingPhase 3Joincare Pharmaceutical Group Industry Co., LtdNCT07357051Written as Oseltamivir
- A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for SuspensionNot yet recruitingPhase 3Jiangxi Kvvit Pharmaceutical Co., Ltd.NCT07113392Written as Oseltamivir
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsCompletedPhase 3Hoffmann-La RocheNCT06774859Written as Oseltamivir
- Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With InfluenzaCompletedPhase 3Nanjing Zenshine PharmaceuticalsNCT07095257Written as Oseltamivir phosphate for oral suspension
- Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza AActive, not recruitingPhase 3Guangdong Raynovent Biotech Co., LtdNCT07229807Written as Oseltamivir
- Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)CompletedPhase 1Merck Sharp & Dohme LLCNCT05818124Written as Oseltamivir
- A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza ACompletedPhase 3Guangdong Raynovent Biotech Co., LtdNCT04683406Written as Oseltamivir(oral)
- Baloxavir Versus Oseltamivir for Nursing Home Influenza OutbreaksStatus unknownPhase 4Insight Therapeutics, LLCNCT05012189Written as Oseltamivir
- Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated InfluenzaCompletedPhase 3BioCryst PharmaceuticalsNCT02369159Written as Oseltamivir
- The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19Status unknownPhase 3Indonesia UniversityNCT04558463Written as Oseltamivir 75mg
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsCompletedPhase 3Hoffmann-La RocheNCT03629184Written as Oseltamivir
- Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of InfluenzaCompletedPhase 4Materia Medica HoldingNCT01850446Written as Oseltamivir
- Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza ComplicationsCompletedPhase 3ShionogiNCT02949011Written as Oseltamivir
- Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like SymptomsStatus unknownNot applicableJiangxi Qingfeng Pharmaceutical Co. Ltd.NCT03947411Written as Oseltamivir Phosphate
- A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With InfluenzaCompletedPhase 3ShionogiNCT02954354Written as Oseltamivir
- A Multinational Phase III Study of CS-8958 (MARVEL)CompletedPhase 3Daiichi Sankyo Co., Ltd.NCT00803595Written as oseltamivir phosphate
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With InfluenzaCompletedPhase 3GlaxoSmithKlineNCT01231620Written as Oseltamivir
- A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge ModelCompletedPhase 2Genentech, Inc.NCT01980966Written as oseltamivir [Tamiflu]
- Banlangen Granules Anti-seasonal Influenza StudyStatus unknownPhase 4Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company LimitedNCT02232945Written as oseltamivir phosphate
- Lingdancao Granules in the Treatment of Seasonal InfluenzaStatus unknownPhase 3The First Affiliated Hospital of Guangzhou Medical UniversityNCT02662426Written as Oseltamivir phosphate capsule
Showing 20 of 23.
Codes
What other systems call Oseltamivir · ClinicalTrials.gg INT008880
- MeSH (NLM) D053139OseltamivirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 20O93L6F9HOSELTAMIVIRConfirmed FDA, NLM, Wikidata
- RxNorm 260101Confirmed FDA, Wikidata
- Wikidata Q211509oseltamivirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62061OseltamivirOne source FDA
- DrugBank DB00198One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D053139 | Oseltamivir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 20O93L6F9H | OSELTAMIVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 260101 | — | Confirmed FDA, Wikidata |
| Wikidata | Q211509 | oseltamivir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62061 | Oseltamivir | One source FDA |
| DrugBank | DB00198 | — | One source Wikidata |
Also registered as oseltamivir phosphate (UNII 4A3O49NGEZ · RxNorm 259275).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.